Federal contract award
75F40125P00102
PURCHASE OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED (HIPSC) CELLS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $89.7K |
| Current contract value | $89.7K |
| Potential contract value / ceiling | $89.7K |
| Start date | Jul 1, 2025 |
| Current end date | Jun 29, 2026 |
| Potential end date | Jun 29, 2026 |
| Latest award activity | Jul 1, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 1, 2025 | 0 | $89.7K | PURCHASE OF HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED (HIPSC) CELLS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.